Details for Patent: 7,727,984
✉ Email this page to a colleague
Which drugs does patent 7,727,984 protect, and when does it expire?
Patent 7,727,984 protects STIOLTO RESPIMAT and STRIVERDI RESPIMAT and is included in two NDAs.
This patent has fifty-one patent family members in thirty-six countries.
Summary for Patent: 7,727,984
| Title: | Medicaments for the treatment of chronic obstructive pulmonary disease |
| Abstract: | A pharmaceutical composition comprising a compound of formula 1 ##STR00001## wherein: n is 1 or 2; R.sup.1 is hydrogen, C.sub.1-C.sub.4-alkyl, halogen, OH, or --O--C.sub.1-C.sub.4-alkyl; R.sup.2 is hydrogen, C.sub.1-C.sub.4-alkyl, halogen, OH, or --O--C.sub.1-C.sub.4-alkyl; R.sup.3 is hydrogen, C.sub.1-C.sub.4-alkyl, OH, halogen, --O--C.sub.1-C.sub.4-alkyl, --O--C.sub.1-C.sub.4-alkylene-COOH, or --O--C.sub.1-C.sub.4-alkylene-CO--O--C.sub.1-C.sub.4-alkyl, or an acid addition salt thereof with a pharmacologically acceptable acid, or a solvate or hydrate thereof; and a pharmaceutically acceptable excipient or carrier, and methods for using the pharmaceutical formulation in the treatment of chronic obstructive pulmonary disease (COPD). |
| Inventor(s): | Konetzki; Ingo (Warthausen, DE), Schromm; Kurt (Ingelheim am Rhein, DE), Schollenberger; Hermann (Ingelheim am Rhein, DE), Pestel; Sabine (Biberach, DE), Schnapp; Andreas (Biberach, DE), Bouyssou; Thierry (Mietingen, DE), Buettner; Frank (Ummendorf, DE), Heine; Claudia (Biberach, DE), Lustenberger; Philipp (Warthausen, DE), Hoenke; Christoph (Ingelheim, DE), Rudolf; Klaus (Warthausen, DE) |
| Assignee: | Boehringer Ingelheim Pharma GmbH & Co., KG (Ingelheim, DE) |
| Application Number: | 11/677,112 |
|
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 7,727,984
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | STIOLTO RESPIMAT | olodaterol hydrochloride; tiotropium bromide | SPRAY, METERED;INHALATION | 206756-001 | May 21, 2015 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| Boehringer Ingelheim | STRIVERDI RESPIMAT | olodaterol hydrochloride | SPRAY, METERED;INHALATION | 203108-001 | Jul 31, 2014 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,727,984
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 102 53 282 | Nov 15, 2002 |
International Family Members for US Patent 7,727,984
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1562603 | ⤷ Subscribe | C300650 | Netherlands | ⤷ Subscribe |
| European Patent Office | 1562603 | ⤷ Subscribe | PA2014012 | Lithuania | ⤷ Subscribe |
| European Patent Office | 1562603 | ⤷ Subscribe | 92433 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 1562603 | ⤷ Subscribe | CR 2014 00014 | Denmark | ⤷ Subscribe |
| European Patent Office | 1562603 | ⤷ Subscribe | C20140010 00101 | Estonia | ⤷ Subscribe |
| European Patent Office | 1562603 | ⤷ Subscribe | 159 5009-2014 | Slovakia | ⤷ Subscribe |
| European Patent Office | 1562603 | ⤷ Subscribe | 1490016-1 | Sweden | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
